On 9-12 July 2023, the city of Maastricht, Netherlands, will host the 28th Annual Congress of the European Society of Biomechanics (ESBiomech2023).

In such context, the SIMCor consortium is involved, amongst others, in the organisation of a course series entitled “In-silico trials and virtual cohorts for device testing”.

The course will encompass (1) state-of-the-art modelling approaches for device testing (AI-based, mechanistic and hybrid modelling) and some current applications; (2) methodologies for virtual cohort generation, multi-level validation and some use case applications; (3) status quo and future perspectives of in-silico device trials, including advantages with respect to traditional patient-based trials, strategies for mapping engineering metrics to clinical endpoints, implementation and regulatory considerations. 

The course series will leverage current research in the field, as well as the work and lessons learnt from the SIMCor and other relevant in-silico medicine projects. 

The course will be open upon subscription and will take place on Sunday 9 July, from 10:30 to 18:00.